Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy
Publication date: Available online 15 October 2026 Source: AACE Endocrinology and Diabetes Author(s): Youssef Abdullah, Elie Naous, Nurhan Torun, Anna Z. Feldman
Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy. // Academic Pediatrics. – URL: https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all
Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy. Academic Pediatrics. https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all
“Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy.” Academic Pediatrics.
@article{article2373,
title = {Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy},
journal = {Academic Pediatrics},
url = {https://www.sciencedirect.com/science/article/pii/S3050915726002638?dgcid=rss_sd_all}
}
Publication date: Available online 14 November 2026 Source: AACE Endocrinology and Diabetes Author(s): Laura Pierotti, Chiara Sardella, Simone Della Valentina, Anna Dal Lago, Giacomo De Leo, Filomena Cetani